<p>, /PRNewswire/ -- JND 法律管理</p>
<p><strong>特拉華州衡平法院</strong></p>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>MILANA NEMETH 和 ADAM SAAB，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>代表他們自己及所有類似情況的其他人，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>原告，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>v.</td>
<td></td>
<td></td>
</tr>
<tr>
<td>ELI D. CASDIN, KEITH A. MEISTER，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>CHRISTIAN HENRY, KWAME OWUSU-</td>
<td></td>
<td></td>
</tr>
<tr>
<td>KESSE, CHAD ROBINS, HARLAN ROBINS，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>AMY ABERNETHY, BRIAN EMES, SHAUN</td>
<td></td>
<td></td>
</tr>
<tr>
<td>RODRIGUEZ, CMLS HOLDINGS III LLC，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>CORVEX MANAGEMENT LP, CASDIN</td>
<td></td>
<td></td>
</tr>
<tr>
<td>CAPITAL, LLC, REVOLUTION MEDICINES，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>INC. 和 ALEXIS BORISY，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>被告。</td>
<td>)</td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td>C.A. No. 2024-1268-PAF</td>
<td></td>
</tr>
</tbody>
</table>
<p><strong>待決事項及擬議的</strong></p>
<p><strong>股東集體訴訟和解</strong></p>
<p><strong>聽證會及出庭權利</strong></p>
<p><strong>致：</strong> <strong>所有 CM 生命科學 III 公司（&#34;CMLS III&#34;）A 類普通股的記錄和實益持有者，他們在 2021 年 12 月 14 日下午 5:00（東部時間）贖回截止日期後立即持有該股票，包括通過法律操作獲得股份的繼承人</strong></p>
<p><strong>本通知經特拉華州衡平法院（&#34;法院&#34;）授權。此通知不是律師招攬。請仔細閲讀本通知及其全部內容。您的權利將受到正在法院進行的集體訴訟的影響。</strong></p>
<p>根據法院的命令和衡平法院規則第 23 條，特此通知您：(i) 上述標題的訴訟（&#34;訴訟&#34;）已初步認證為代表所有 CMLS III A 類普通股（&#34;A 類普通股&#34;）的記錄和實益持有者的集體訴訟，包括通過法律操作獲得股份的繼承人，但不包括某些被排除人員（&#34;集體&#34;）；(ii) 原告和訴訟中的被告已達成協議，以 725 萬美元現金（&#34;和解&#34;）解決訴訟。如果和解獲得批准，將解決訴訟中的所有索賠。本摘要通知中使用的任何大寫術語，如未在此處另行定義，應具有在 2026 年 1 月 5 日簽署的妥協、和解和解除協議（&#34;協議&#34;）及股東集體訴訟、和解聽證會及出庭權利的待決事項和擬議和解通知（&#34;通知&#34;）中賦予的含義，副本可在 www.cmlsiiistockholdersettlement.com 獲取。</p>
<p>聽證會將於 2026 年 4 月 21 日下午 1:30 在特拉華州衡平法院，由尊敬的保羅·A·菲奧拉萬提副法官主持，地點為萊昂納德·L·威廉姆斯司法中心，北金街 500 號，威爾明頓，DE 19801，目的是確定：(i) 是否僅為和解目的最終認證集體，依據衡平法院規則 23(a)、23(b)(1) 和 23(b)(2)；(ii) 原告和原告律師是否充分代表集體，原告是否應最終被任命為集體代表，原告律師是否應最終被任命為集體律師；(iii) 擬議的和解是否應被批准為公平、合理且對原告及其他集體成員的最佳利益；(iv) 是否應根據協議進入批准和解、以偏見駁回訴訟並授予協議下的解除的擬議命令和最終判決；(v) 擬議的淨和解基金分配計劃是否公平合理，因此應獲得批准；(vi) 是否以及以何種金額應從和解基金中支付任何費用和支出獎勵給原告律師，包括任何服務獎勵僅從任何費用和支出獎勵中支付給原告；(vii) 聽取並裁定對和解、擬議的分配計劃、原告律師申請費用和支出獎勵及/或任何服務獎勵的任何異議；(viii) 考慮與和解相關的任何其他事項。</p>
<p>如果您在 2021 年 12 月 14 日持有 CMLS III A 類普通股，無論是記錄持有還是實益持有，您的權利可能會受到本訴訟和解的影響。如果您尚未收到詳細通知和索賠及解除證明表（&#34;索賠證明&#34;）的副本，您可以通過寫信至 CMLS III 股東和解，和解管理員，JND 法律管理，郵政信箱 91222，西雅圖，WA 98111，或在 www.cmlsiiistockholdersettlement.com 下載此信息來獲取副本。如果您是集體成員，為了分享淨和解基金的分配，您必須在 <strong>2026 年 5 月 25 日</strong> 之前在線提交索賠證明，或通過郵寄方式在 <strong>2026 年 5 月 25 日</strong> 之前送達，以證明您有權獲得賠償。1</p>
<p>該集體是根據衡平法院規則 23(a)、23(b)(1) 和 23(b)(2) 的非&#34;選擇退出&#34;集體。因此，集體成員將受限於根據協議條款和條件在訴訟中作出的任何判決。</p>
<p>對和解的任何異議必須在以下地址向衡平法院登記處提交，並送達原告律師和被告律師（通過 File &amp; Serve _Xpress_電子方式、親自、通過美國郵政一類郵件、快遞服務或電子郵件）至以下地址，確保在 <strong>2026 年 4 月 7 日</strong> 之前收到：</p>
<p><strong>衡平法院登記處</strong></p>
<p>衡平法院登記處</p>
<p>特拉華州衡平法院</p>
<p>萊昂納德·L·威廉姆斯司法中心</p>
<p>北金街 500 號</p>
<p>威爾明頓，DE 19801</p>
<p><strong>原告律師</strong></p>
<p>格雷戈裏·E·德爾·蓋佐</p>
<p>羅賓斯律師事務所</p>
<p>5060 Shoreham Place, Suite 300</p>
<p>聖地亞哥，CA 92122</p>
<p>[email protected]</p>
<p>凱莉·L·塔克</p>
<p>格蘭特與艾森霍弗律師事務所</p>
<p>德拉瓦州威明頓市 123 Justison Street, 7 樓</p>
<p>郵政編碼 19801</p>
<p>[email protected]</p>
<p><strong>被告律師</strong></p>
<p>德博拉·S·伯恩巴赫</p>
<p>Goodwin Procter LLP</p>
<p>北大道 100 號</p>
<p>馬薩諸塞州波士頓 02210</p>
<p>[email protected]</p>
<p>格雷戈裏·斯塔納</p>
<p>美洲大道 1221 號</p>
<p>紐約市，紐約州 10020</p>
<p>[email protected]</p>
<p><strong>請勿就此通知聯繫法院、註冊官、被告或被告律師</strong>。如果您對和解有任何疑問，可以通過上述地址聯繫原告的律師，撥打電話 (302) 622-7000 或 (619) 525-3990，或訪問以下網站：www.cmlsiiistockholdersettlement.com。</p>
<p>根據德拉瓦州衡平法院的命令</p>
<p>1 證明索賠的郵戳日期不得晚於 <strong>2026 年 5 月 25 日</strong>，將視為在郵戳日期收到。請注意，美國郵政服務可能不會對未親自遞交的郵件進行郵戳。</p>
<p>來源 JND 法律行政管理</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjEzJk5ld3NJdGVtSWQ9TEE3NjgzOCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMTMwOTEzUFJfTkVXU19VU1BSX19fX19MQTc2ODM4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjEzJk5ld3NJdGVtSWQ9TEE3NjgzOCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMTMwOTEzUFJfTkVXU19VU1BSX19fX19MQTc2ODM4"/></p>

基因免疫&健康關懷 ETF - iShares

納斯達克生物科技指數 ETF - iShares Nasdaq

生物科技 ETF - VanEck Vectors

標普生物技術 ETF - SPDR

2 倍做多納斯達克生物技術 ETF - ProShares

紐交所高增長板生物技術指數 ETF - First Trust

動態生物技術與基因組 ETF - Invesco

OLSI

MDLS

<p>CM Life Sciences III, Inc. A 類普通股股東集體訴訟的待決通知和擬議和解。已提議一項 725 萬美元的和解，影響截至 2021 年 12 月 14 日的所有登記和實際持有該股票的股東。聽證會定於 2026 年 4 月 21 日舉行，以決定和解及相關事項的批准。集體成員必須提交索賠證明以參與和解基金的分配</p>

<p>, /PRNewswire/ -- JND Legal Administration</p>
<div class="lb-trans"><p>, /PRNewswire/ -- JND 法律管理</p>
</div><p><strong>IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE</strong></p>
<div class="lb-trans"><p><strong>特拉華州衡平法院</strong></p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>MILANA NEMETH and ADAM SAAB,<br/>individually on behalf of themselves and all<br/>others similarly situated,<br/>Plaintiffs,<br/>v.<br/>ELI D. CASDIN, KEITH A. MEISTER,<br/>CHRISTIAN HENRY, KWAME OWUSU-<br/>KESSE, CHAD ROBINS, HARLAN ROBINS,<br/>AMY ABERNETHY, BRIAN EMES, SHAUN<br/>RODRIGUEZ, CMLS HOLDINGS III LLC,<br/>CORVEX MANAGEMENT LP, CASDIN<br/>CAPITAL, LLC, REVOLUTION MEDICINES,<br/>INC., and ALEXIS BORISY,<br/>Defendants.</td>
<td>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)</td>
<td>C.A. No. 2024-1268-PAF</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>MILANA NEMETH 和 ADAM SAAB，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>代表他們自己及所有類似情況的其他人，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>原告，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>v.</td>
<td></td>
<td></td>
</tr>
<tr>
<td>ELI D. CASDIN, KEITH A. MEISTER，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>CHRISTIAN HENRY, KWAME OWUSU-</td>
<td></td>
<td></td>
</tr>
<tr>
<td>KESSE, CHAD ROBINS, HARLAN ROBINS，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>AMY ABERNETHY, BRIAN EMES, SHAUN</td>
<td></td>
<td></td>
</tr>
<tr>
<td>RODRIGUEZ, CMLS HOLDINGS III LLC，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>CORVEX MANAGEMENT LP, CASDIN</td>
<td></td>
<td></td>
</tr>
<tr>
<td>CAPITAL, LLC, REVOLUTION MEDICINES，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>INC. 和 ALEXIS BORISY，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>被告。</td>
<td>)</td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td>C.A. No. 2024-1268-PAF</td>
<td></td>
</tr>
</tbody>
</table>
</div><p><strong>SUMMARY NOTICE OF PENDENCY AND PROPOSED</strong></p>
<div class="lb-trans"><p><strong>待決事項及擬議的</strong></p>
</div><p><strong>SETTLEMENT OF STOCKHOLDER CLASS ACTION, SETTLEMENT</strong></p>
<div class="lb-trans"><p><strong>股東集體訴訟和解</strong></p>
</div><p><strong>HEARING, AND RIGHT TO APPEAR</strong></p>
<div class="lb-trans"><p><strong>聽證會及出庭權利</strong></p>
</div><p><strong>TO:</strong> <strong>ALL RECORD AND BENEFICIAL HOLDERS OF CM LIFE SCIENCES III, INC. (&#34;CMLS III&#34;) CLASS A COMMON STOCK WHO HELD SUCH STOCK IMMEDIATELY FOLLOWING THE REDEMPTION DEADLINE OF 5:00 PM ET ON DECEMBER 14, 2021, INCLUDING THEIR SUCCESSORS IN INTEREST WHO OBTAINED SHARES BY OPERATION OF LAW</strong></p>
<div class="lb-trans"><p><strong>致：</strong> <strong>所有 CM 生命科學 III 公司（&#34;CMLS III&#34;）A 類普通股的記錄和實益持有者，他們在 2021 年 12 月 14 日下午 5:00（東部時間）贖回截止日期後立即持有該股票，包括通過法律操作獲得股份的繼承人</strong></p>
</div><p><strong>THIS NOTICE WAS AUTHORIZED BY THE COURT OF CHANCERY OF THE STATE OF DELAWARE (THE &#34;COURT&#34;). IT IS NOT A LAWYER SOLICITATION. PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY. YOUR RIGHTS WILL BE AFFECTED BY A CLASS ACTION LAWSUIT PENDING IN THE COURT</strong>.</p>
<div class="lb-trans"><p><strong>本通知經特拉華州衡平法院（&#34;法院&#34;）授權。此通知不是律師招攬。請仔細閲讀本通知及其全部內容。您的權利將受到正在法院進行的集體訴訟的影響。</strong></p>
</div><p>YOU ARE HEREBY NOTIFIED, pursuant to an Order of the Court and Court of Chancery Rule 23, that: (i) the above-captioned action (the &#34;Action&#34;) has been preliminarily certified as a class action on behalf of a class of all record and beneficial holders of CMLS III Class A Common Stock (&#34;Class A Common Stock&#34;) during the Class Period, including successors-in-interest who obtained shares by operation of law, but excluding certain Excluded Persons (the &#34;Class&#34;); and (ii) Plaintiffs and Defendants in the Action have reached an agreement to settle the Action for $7,250,000 in cash (the &#34;Settlement&#34;). If the Settlement is approved, it will resolve all claims in the Action. Any capitalized terms used in this Summary Notice that are not otherwise defined herein shall have the meanings ascribed to them in the Stipulation and Agreement of Compromise, Settlement, and Release dated January 5, 2026 (the &#34;Stipulation&#34;), and the Notice of Pendency and Proposed Settlement of Stockholder Class Action, Settlement Hearing, and Right to Appear (&#34;Notice&#34;), copies of which can be obtained at www.cmlsiiistockholdersettlement.com.</p>
<div class="lb-trans"><p>根據法院的命令和衡平法院規則第 23 條，特此通知您：(i) 上述標題的訴訟（&#34;訴訟&#34;）已初步認證為代表所有 CMLS III A 類普通股（&#34;A 類普通股&#34;）的記錄和實益持有者的集體訴訟，包括通過法律操作獲得股份的繼承人，但不包括某些被排除人員（&#34;集體&#34;）；(ii) 原告和訴訟中的被告已達成協議，以 725 萬美元現金（&#34;和解&#34;）解決訴訟。如果和解獲得批准，將解決訴訟中的所有索賠。本摘要通知中使用的任何大寫術語，如未在此處另行定義，應具有在 2026 年 1 月 5 日簽署的妥協、和解和解除協議（&#34;協議&#34;）及股東集體訴訟、和解聽證會及出庭權利的待決事項和擬議和解通知（&#34;通知&#34;）中賦予的含義，副本可在 www.cmlsiiistockholdersettlement.com 獲取。</p>
</div><p>A hearing will be held on April 21, 2026, at 1:30 p.m., before the Honorable Paul A. Fioravanti, Vice Chancellor, at the Court of Chancery of the State of Delaware, Leonard L. Williams Justice Center, 500 North King Street, Wilmington, DE 19801, for the purpose of determining: (i) whether to finally certify the Class for settlement purposes only, pursuant to Court of Chancery Rules 23(a), 23(b)(1), and 23(b)(2); (ii) whether Plaintiffs and Plaintiffs' Counsel have adequately represented the Class, and whether Plaintiffs should be finally appointed as Class Representatives for the Class and Plaintiffs' Counsel should be finally appointed as Class Counsel for the Class; (iii) whether the proposed Settlement should be approved as fair, reasonable, and adequate to Plaintiffs and the other members of the Class and in their best interests; (iv) whether the proposed Order and Final Judgment approving the Settlement, dismissing the Action with prejudice, and granting the Releases provided under the Stipulation should be entered; (v) whether the proposed Plan of Allocation of the Net Settlement Fund is fair and reasonable, and should therefore be approved; (vi) whether and in what amount any Fee and Expense Award to Plaintiffs' Counsel should be paid out of the Settlement Fund, including any service award to Plaintiffs to be paid solely from any Fee and Expense Award; (vii) to hear and rule on any objections to the Settlement, the proposed Plan of Allocation, Plaintiffs' Counsel's application for a Fee and Expense Award, and/or any service award to Plaintiffs; and (viii) to consider any other matters that may properly be brought before the Court in connection with the Settlement.</p>
<div class="lb-trans"><p>聽證會將於 2026 年 4 月 21 日下午 1:30 在特拉華州衡平法院，由尊敬的保羅·A·菲奧拉萬提副法官主持，地點為萊昂納德·L·威廉姆斯司法中心，北金街 500 號，威爾明頓，DE 19801，目的是確定：(i) 是否僅為和解目的最終認證集體，依據衡平法院規則 23(a)、23(b)(1) 和 23(b)(2)；(ii) 原告和原告律師是否充分代表集體，原告是否應最終被任命為集體代表，原告律師是否應最終被任命為集體律師；(iii) 擬議的和解是否應被批准為公平、合理且對原告及其他集體成員的最佳利益；(iv) 是否應根據協議進入批准和解、以偏見駁回訴訟並授予協議下的解除的擬議命令和最終判決；(v) 擬議的淨和解基金分配計劃是否公平合理，因此應獲得批准；(vi) 是否以及以何種金額應從和解基金中支付任何費用和支出獎勵給原告律師，包括任何服務獎勵僅從任何費用和支出獎勵中支付給原告；(vii) 聽取並裁定對和解、擬議的分配計劃、原告律師申請費用和支出獎勵及/或任何服務獎勵的任何異議；(viii) 考慮與和解相關的任何其他事項。</p>
</div><p>If you held shares of CMLS III Class A Common Stock, either of record or beneficially, as of December 14, 2021, your rights may be affected by the settlement of this Action. If you have not received a detailed Notice and a copy of the Proof of Claim and Release form (&#34;Proof of Claim&#34;), you may obtain copies (as well as a copy of the Stipulation) by writing to CMLS III Stockholder Settlement, Settlement Administrator, c/o JND Legal Administration, P.O. Box 91222, Seattle, WA 98111 or by downloading this information at www.cmlsiiistockholdersettlement.com. If you are a member of the Class, in order to share in the distribution of the Net Settlement Fund, you must either submit a Proof of Claim online at www.cmlsiiistockholdersettlement.com by <strong>May 25, 2026</strong> or by mail to be received no later than <strong>May 25, 2026</strong>, establishing that you are entitled to a recovery.1</p>
<div class="lb-trans"><p>如果您在 2021 年 12 月 14 日持有 CMLS III A 類普通股，無論是記錄持有還是實益持有，您的權利可能會受到本訴訟和解的影響。如果您尚未收到詳細通知和索賠及解除證明表（&#34;索賠證明&#34;）的副本，您可以通過寫信至 CMLS III 股東和解，和解管理員，JND 法律管理，郵政信箱 91222，西雅圖，WA 98111，或在 www.cmlsiiistockholdersettlement.com 下載此信息來獲取副本。如果您是集體成員，為了分享淨和解基金的分配，您必須在 <strong>2026 年 5 月 25 日</strong> 之前在線提交索賠證明，或通過郵寄方式在 <strong>2026 年 5 月 25 日</strong> 之前送達，以證明您有權獲得賠償。1</p>
</div><p>The Class is a non-&#34;opt-out&#34; class pursuant to Court of Chancery Rules 23(a), 23(b)(1), and 23(b)(2). Accordingly, Class Members will be bound by any judgment entered in the Action pursuant to the terms and conditions of the Stipulation.</p>
<div class="lb-trans"><p>該集體是根據衡平法院規則 23(a)、23(b)(1) 和 23(b)(2) 的非&#34;選擇退出&#34;集體。因此，集體成員將受限於根據協議條款和條件在訴訟中作出的任何判決。</p>
</div><p>Any objection to the Settlement must be filed with the Register in Chancery at the address set forth below and served on Plaintiffs' Counsel and Defendants' Counsel (electronically by File &amp; Serve <em>Xpress</em>, by hand, by first-class U.S. mail, by express service, or by email) at the addresses below, such that it is received no later than <strong>April 7, 2026</strong>:</p>
<div class="lb-trans"><p>對和解的任何異議必須在以下地址向衡平法院登記處提交，並送達原告律師和被告律師（通過 File &amp; Serve _Xpress_電子方式、親自、通過美國郵政一類郵件、快遞服務或電子郵件）至以下地址，確保在 <strong>2026 年 4 月 7 日</strong> 之前收到：</p>
</div><p><strong>REGISTER IN CHANCERY</strong></p>
<div class="lb-trans"><p><strong>衡平法院登記處</strong></p>
</div><p>Register in Chancery</p>
<div class="lb-trans"><p>衡平法院登記處</p>
</div><p>Court of Chancery of the State of Delaware</p>
<div class="lb-trans"><p>特拉華州衡平法院</p>
</div><p>Leonard L. Williams Justice Center</p>
<div class="lb-trans"><p>萊昂納德·L·威廉姆斯司法中心</p>
</div><p>500 North King Street</p>
<div class="lb-trans"><p>北金街 500 號</p>
</div><p>Wilmington, DE 19801</p>
<div class="lb-trans"><p>威爾明頓，DE 19801</p>
</div><p><strong>PLAINTIFF'S COUNSEL</strong></p>
<div class="lb-trans"><p><strong>原告律師</strong></p>
</div><p>Gregory E. Del Gaizo</p>
<div class="lb-trans"><p>格雷戈裏·E·德爾·蓋佐</p>
</div><p>Robbins LLP</p>
<div class="lb-trans"><p>羅賓斯律師事務所</p>
</div><p>5060 Shoreham Place, Suite 300</p>
<div class="lb-trans"><p>5060 Shoreham Place, Suite 300</p>
</div><p>San Diego, CA 92122</p>
<div class="lb-trans"><p>聖地亞哥，CA 92122</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>Kelly L. Tucker</p>
<div class="lb-trans"><p>凱莉·L·塔克</p>
</div><p>Grant &amp; Eisenhofer P.A.</p>
<div class="lb-trans"><p>格蘭特與艾森霍弗律師事務所</p>
</div><p>123 Justison Street, 7th Floor</p>
<div class="lb-trans"><p>德拉瓦州威明頓市 123 Justison Street, 7 樓</p>
</div><p>Wilmington, DE 19801</p>
<div class="lb-trans"><p>郵政編碼 19801</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p><strong>DEFENDANTS' COUNSEL</strong></p>
<div class="lb-trans"><p><strong>被告律師</strong></p>
</div><p>Deborah S. Birnbach</p>
<div class="lb-trans"><p>德博拉·S·伯恩巴赫</p>
</div><p>Goodwin Procter LLP</p>
<div class="lb-trans"><p>Goodwin Procter LLP</p>
</div><p>100 Northern Avenue</p>
<div class="lb-trans"><p>北大道 100 號</p>
</div><p>Boston, MA 02210</p>
<div class="lb-trans"><p>馬薩諸塞州波士頓 02210</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>Gregory Starner</p>
<div class="lb-trans"><p>格雷戈裏·斯塔納</p>
</div><p>1221 Avenue of the Americas</p>
<div class="lb-trans"><p>美洲大道 1221 號</p>
</div><p>New York, New York 10020</p>
<div class="lb-trans"><p>紐約市，紐約州 10020</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p><strong>PLEASE DO NOT CONTACT THE COURT, THE REGISTER IN CHANCERY, DEFENDANTS, OR DEFENDANTS' COUNSEL REGARDING THIS NOTICE</strong>. If you have any questions about the Settlement, you may contact counsel for Plaintiffs at the addresses listed above, call (302) 622-7000, or (619) 525-3990, or go to the following website: www.cmlsiiistockholdersettlement.com.</p>
<div class="lb-trans"><p><strong>請勿就此通知聯繫法院、註冊官、被告或被告律師</strong>。如果您對和解有任何疑問，可以通過上述地址聯繫原告的律師，撥打電話 (302) 622-7000 或 (619) 525-3990，或訪問以下網站：www.cmlsiiistockholdersettlement.com。</p>
</div><p>BY ORDER OF THE COURT OF CHANCERY</p>
<div class="lb-trans"><p>根據德拉瓦州衡平法院的命令</p>
</div><p>OF THE STATE OF DELAWARE</p>
<div class="lb-trans"><p>1 證明索賠的郵戳日期不得晚於 <strong>2026 年 5 月 25 日</strong>，將視為在郵戳日期收到。請注意，美國郵政服務可能不會對未親自遞交的郵件進行郵戳。</p>
</div><p>1 Proofs of Claim that are legibly postmarked no later than <strong>May 25, 2026</strong> will be treated as received on the postmark date. Please be advised that the U.S. Postal Service may not postmark mail which is not presented in person.</p>
<p>SOURCE JND Legal Administration</p>
<div class="lb-trans"><p>來源 JND 法律行政管理</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjEzJk5ld3NJdGVtSWQ9TEE3NjgzOCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMTMwOTEzUFJfTkVXU19VU1BSX19fX19MQTc2ODM4" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA76838&amp;Transmission_Id=202602130913PR_NEWS_USPR_____LA76838&amp;DateId=20260213"/></p>

09:13 ETNotice of Pendency and Proposed Settlement of Stockholder Class Action Involving All Record and Beneficial Holders of CM Life Sciences III, Inc. Class A Common Stock on December 14, 2021

prnewswire

Origin Life Sciences

Caris Life Sciences

MDNA Life Sciences, Inc.

關於 CM Life Sciences III, Inc. A 類普通股的股東集體訴訟的待決通知和擬議和解，涉及所有在2021年12月14日持有記錄和受益的股東